Name | (1R,7S)-3-(2,4-Difluorophenyl)-N-(2-methyl-2-propanyl)-3,4-diazatricyclo[5.2.1.02,6]deca-2(6),4-diene-5-carboxamide |
---|
Description | Tedalinab (GRC-10693) is a potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist. Tedalinab has >4700-fold functional selectivity for CB2 over CB1. Tedalinab has potential for neuropathic pain and osteoarthritis treatment[1]. |
---|---|
Related Catalog | |
Target |
CB2 |
References |
Molecular Formula | C19H21F2N3O |
---|---|
Molecular Weight | 345.38600 |
Exact Mass | 345.16500 |
PSA | 50.41000 |
LogP | 4.61830 |